A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

SAS System for Mixed Models

1996 • 10,609 citations

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

1996 • 3,809 citations

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 • 2,293 citations

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

1996 • 1,002 citations

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

1994 • 694 citations

The crippling consequences of fractures and their impact on quality of life

1997 • 683 citations

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis

1996 • 619 citations

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

1997 • 527 citations

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

1992 • 443 citations

Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling

1995 • 366 citations

THE EFFECTS OF PARATHYROID HORMONE, COLCHICINE, AND CALCITONIN ON THE ULTRASTRUCTURE AND THE ACTIVITY OF OSTEOCLASTS IN ORGAN CULTURE

1974 • 343 citations

Long-term calcitonin therapy in postmenopausal osteoporosis

1984 • 332 citations

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

1992 • 293 citations

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1994 • 281 citations

1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN

1987 • 203 citations

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

1992 • 193 citations

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

1996 • 188 citations

Ultrastructural effects of calcitonin on osteoclasts in tissue culture

1972 • 186 citations

Effect of salcatonin given intranasally on early postmenopausal bone loss.

1989 • 180 citations

NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS

1989 • 169 citations

The calcitonins; physiology and pharmacology

1990 • 161 citations

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.

1994 • 152 citations

An evaluation of antibodies and clinical resistance to salmon calcitonin

1972 • 139 citations

Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures

1995 • 128 citations

Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

1995 • 123 citations

Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment

1990 • 111 citations

Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis

1996 • 106 citations

Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: A prospective study

1995 • 92 citations

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

1995 • 87 citations

Dual X‐ray absorptiometry quality control: Comparison of visual examination and process‐control charts

1996 • 85 citations

Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study

1994 • 85 citations

Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis

1996 • 81 citations

Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats

1981 • 74 citations

Formation of Neutralizing Antibodies During Intranasal Synthetic Salmon Calcitonin Treatment of Paget's Disease*

1988 • 71 citations

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

1994 • 70 citations

Comparative calibration without a gold standard

1997 • 56 citations

Quantification of skeletal alkaline phosphatase in osteoporotic serum by wheat germ agglutinin precipitation, heat inactivation, and a two-site immunoradiometric assay

1994 • 55 citations

Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis

1991 • 52 citations

Effects of calcitonin on bone quality and osteoblastic function

1993 • 52 citations

The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: Evidence of maximal effect after 8 weeks of continuous treatment

1996 • 44 citations

A 5‐year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium

1994 • 43 citations

Effect of Salmon Calcitonin on Femoral Bone Quality in Adult Ovariectomized Ewes

1996 • 40 citations

Exploiting and Bypassing the Bone Remodeling Cycle to Optimize the Treatment of Osteoporosis

1997 • 40 citations

Long-term treatment of established osteoporosis with intranasal calcitonin

1991 • 37 citations

The role of skeletal calcium deficiency in postmenopausal osteoporosis

1986 • 33 citations

In vitro detection of neutralizing antibodies after treatment of paget's disease of bone with nasal salmon calcitonin

1990 • 31 citations

The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis

1998 • 21 citations

Calcitonin effects on rabbit bone

1992 • 16 citations

A double blind study of intranasal calcitonin for established postmenopausal osteoporosis

1997 • 15 citations

The effect of alendronate on rates of vertebral and non-vertebral fractures in women with vertebral fractures: Preliminary results of the fracture intervention trial

1996 • 7 citations